Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Phibro Animal Health Corporation PAHC

Healthcare  —  Drug Manufacturers Specialty & Generic
34.45 0.52 1.53% as of 25 Sep
Market cap
$1.4B
P/E
14.0×
Dividend Champion (10y) Revenue Champion (5y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Phibro Animal Health Corporation (PAHC) Business Profile

Updated before January 2025

Company Overview

Phibro Animal Health Corporation (PAHC) is a global leader in animal health and nutrition, dedicated to improving the health, productivity, and well-being of animals. Founded in 1946, the company has its roots in the chemical industry but transitioned into animal health in the 1970s. Headquartered in Teaneck, New Jersey, PAHC operates in over 65 countries, serving livestock producers, veterinarians, and farmers worldwide. The company is led by its Chairman and CEO, Jack Bendheim, who has been instrumental in steering the company toward innovation and growth. With a strong legacy of over seven decades, PAHC has established itself as a trusted name in the animal health industry.

Core Business Segments

Phibro Animal Health Corporation operates through three primary business segments:

1. Animal Health

This is the company’s largest and most significant segment, accounting for the majority of its revenue. The Animal Health segment focuses on products that enhance the health and productivity of livestock and poultry. Key product categories include:

  • Antibiotics and Antimicrobials: These products help prevent and treat bacterial infections in animals, ensuring their health and productivity.
  • Nutritional Products: Supplements and additives that improve feed efficiency and animal growth.
  • Vaccines: A range of vaccines designed to protect animals from various diseases.
  • Medicated Feed Additives (MFAs): Products that are mixed with animal feed to promote growth and prevent diseases.

2. Mineral Nutrition

This segment provides essential trace minerals and nutritional supplements for livestock. These products are critical for maintaining animal health, improving reproduction, and enhancing overall productivity. The mineral nutrition portfolio includes:

  • Zinc, Copper, and Manganese Supplements: Essential minerals for livestock health.
  • Custom Blends: Tailored mineral solutions to meet specific customer needs.

3. Performance Products

This segment focuses on specialty chemicals and industrial products. While not directly related to animal health, these products support the company’s diversified revenue streams. Key offerings include:

  • Chemical Intermediates: Used in various industrial applications.
  • Specialty Chemicals: Products for niche markets, including personal care and industrial uses.

Business Model

Phibro Animal Health Corporation operates on a vertically integrated business model that combines product development, manufacturing, and distribution. The company invests heavily in research and development (R&D) to create innovative solutions that address the evolving needs of the animal health industry. By maintaining control over its supply chain, PAHC ensures high-quality standards and cost efficiency.

Revenue generation is primarily driven by the sale of products in the Animal Health and Mineral Nutrition segments. The company also leverages long-term relationships with distributors, veterinarians, and livestock producers to maintain a steady revenue stream. Additionally, PAHC’s global presence allows it to tap into diverse markets, reducing dependence on any single region.

Strategic Direction

Phibro Animal Health Corporation is focused on sustainable growth and innovation. Key strategic priorities include:

  • Expansion of Product Portfolio: PAHC aims to develop new vaccines, nutritional products, and feed additives to meet the growing demand for animal health solutions.
  • Geographic Expansion: The company is actively exploring opportunities in emerging markets, where livestock production is on the rise.
  • Sustainability Goals: PAHC is committed to reducing its environmental footprint by adopting sustainable manufacturing practices and promoting responsible use of antibiotics.
  • Digital Transformation: Leveraging technology to enhance customer engagement and streamline operations.

Competitive Landscape

Phibro Animal Health Corporation operates in a highly competitive industry, facing competition from both large multinational corporations and smaller regional players. Key competitors include:

  • Zoetis Inc.: A global leader in animal health, offering a wide range of vaccines and medicines.
  • Elanco Animal Health: Known for its innovative solutions in animal health and nutrition.
  • Boehringer Ingelheim Animal Health: A major player in the animal health sector, focusing on vaccines and therapeutics.
  • Ceva Santé Animale: Specializes in poultry vaccines and other animal health products.

Despite the competition, PAHC differentiates itself through its strong focus on customer relationships, high-quality products, and a diversified portfolio.

Risk Factors

Phibro Animal Health Corporation faces several risks that could impact its operations and financial performance:

  • Market Dependence: A significant portion of the company’s revenue comes from the livestock and poultry sectors, making it vulnerable to fluctuations in these markets.
  • Regulatory Challenges: The animal health industry is heavily regulated, and changes in regulations could affect product approvals and sales.
  • Supply Chain Disruptions: Dependence on raw materials and global supply chains exposes the company to risks such as delays and cost increases.
  • Antibiotic Resistance: Growing concerns about antibiotic resistance could lead to stricter regulations and reduced demand for certain products.

Recent Developments

Phibro Animal Health Corporation has been actively investing in innovation and expanding its product portfolio. Recent developments include:

  • Launch of New Vaccines: The company introduced several new vaccines to address emerging diseases in livestock and poultry.
  • Sustainability Initiatives: PAHC announced plans to reduce greenhouse gas emissions and improve energy efficiency across its operations.
  • Global Expansion: The company entered new markets in Asia and Latin America, strengthening its international presence.
  • Digital Tools: Introduction of digital platforms to provide customers with real-time data and insights for better decision-making.

Investment Considerations

Phibro Animal Health Corporation offers several strengths and risks for potential investors:

Strengths:

  • Diversified product portfolio with a strong focus on animal health.
  • Established global presence with operations in over 65 countries.
  • Commitment to innovation and sustainability.
  • Long-standing relationships with customers and distributors.

Risks:

  • Dependence on livestock and poultry markets.
  • Exposure to regulatory and supply chain risks.
  • Potential impact of antibiotic resistance on product demand.

Conclusion

Phibro Animal Health Corporation is a well-established player in the animal health industry, with a strong legacy and a diversified product portfolio. The company’s focus on innovation, sustainability, and global expansion positions it well for future growth. However, investors should carefully consider the risks associated with market dependence and regulatory challenges. Overall, PAHC remains a promising choice for those looking to invest in the growing animal health sector.